(Q39540331)

12 September 2017

title

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86042

12 November 2022

author name string

W. B. Frijlink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86042

12 November 2022

O. L. Bijvoet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86042

12 November 2022

J. te Velde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86042

12 November 2022

G. Heynen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A86042

12 November 2022

language of work or name

English

0 references

publication date

1 April 1979

1 reference

12 September 2017

14 April 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=86042

full work available at URL

12 November 2022

https://api.elsevier.com/content/article/PII:S0140673679913187?httpAccept=text/xml

1 reference

10.1016/S0140-6736(79)91318-7

DOI

https://api.crossref.org/works/10.1016/S0140-6736(79)91318-7

https://api.elsevier.com/content/article/PII:S0140673679913187?httpAccept=text/plain

12 November 2022

1 reference

10.1016/S0140-6736(79)91318-7

DOI

https://api.crossref.org/works/10.1016/S0140-6736(79)91318-7

12 November 2022

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

8120

1 reference

12 September 2017

page(s)

799-803

1 reference

Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans)

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Diphosphonate Therapy of Paget's Disease of Bone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Effects on growth and modeling of the rat tibia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Etidronate disodium in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Skeletal Renewal and Metabolic Bone Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological a

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991318-7

7 January 2021

10.1016/S0140-6736(79)91318-7

Identifiers

DOI

1 reference

release_2jf5drqzj5hjjlrap6nzihdca4

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2jf5drqzj5hjjlrap6nzihdca4

24 November 2022

mapped directly with Wikidata item

1 reference